Gutless adenovirus: last-generation adenovirus for gene therapy

R Alba, A Bosch, M Chillon - Gene therapy, 2005 - nature.com
Last-generation adenovirus vectors, also called helper-dependent or gutless adenovirus,
are very attractive for gene therapy because the associated in vivo immune response is …

Promoters and control elements: designing expression cassettes for gene therapy

ED Papadakis, SA Nicklin, AH Baker… - Current gene …, 2004 - ingentaconnect.com
It has become apparent that the clinical success anticipated in the field of gene therapy has
been limited by progress in several of the fundamental areas of genetics, molecular and …

In vivo AAV-CRISPR/Cas9–mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia

H Zhao, Y Li, L He, W Pu, W Yu, Y Li, YT Wu, C Xu… - Circulation, 2020 - Am Heart Assoc
Background: Mutations in low-density lipoprotein (LDL) receptor (LDLR) are one of the main
causes of familial hypercholesterolemia, which induces atherosclerosis and has a high …

[HTML][HTML] Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators

AJ Merched, K Ko, KH Gotlinger, CN Serhan… - The FASEB …, 2008 - ncbi.nlm.nih.gov
Atherosclerosis is now recognized as an inflammatory disease involving the vascular wall.
Recent results indicate that acute inflammation does not simply passively resolve as …

Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis

M Dong, X Yang, S Lim, Z Cao, J Honek, H Lu… - Cell metabolism, 2013 - cell.com
Molecular mechanisms underlying the cold-associated high cardiovascular risk remain
unknown. Here, we show that the cold-triggered food-intake-independent lipolysis …

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors

MA Schnell, Y Zhang, J Tazelaar, G Gao, QC Yu… - Molecular Therapy, 2001 - cell.com
The innate immune response to intraportally infused adenoviral vector was evaluated in
rhesus monkeys. A first-generation adenovirus-expressing lacZ (Ad-lacZ) was administered …

Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates

N Brunetti-Pierri, DJ Palmer, AL Beaudet… - Human gene …, 2004 - liebertpub.com
Systemic intravascular delivery of adenoviral (Ad) vectors for liver-directed gene therapy has
been widely employed because of its simplicity, noninvasiveness, and potential for high …

The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor

S Takahashi, J Sakai, T Fujino, H Hattori… - … of atherosclerosis and …, 2004 - jstage.jst.go.jp
The very low-density lipoprotein (VLDL) receptor is a member of the low-density lipoprotein
(LDL) receptor family. In vitro and in vivo studies have shown that VLDL receptor binds …

A sexually dimorphic hepatic cycle of periportal VLDL generation and subsequent pericentral VLDLR-mediated re-uptake

T Martini, C Gobet, A Salati, J Blanc… - Nature …, 2024 - nature.com
Recent single-cell transcriptomes revealed spatiotemporal programmes of liver function on
the sublobular scale. However, how sexual dimorphism affected this space-time logic …

Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis

JL Johnson, AH Baker, K Oka, L Chan, AC Newby… - Circulation, 2006 - Am Heart Assoc
Background—Matrix metalloproteinase (MMP)–associated extracellular matrix degradation
is thought to contribute to the progression and rupture of atherosclerotic plaques. However …